# Effect of Deksmedetomidine and Remifentanil in Extubation Agitation

> **NCT02104297** · PHASE4 · UNKNOWN · sponsor: **Diskapi Yildirim Beyazit Education and Research Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Agitation

## Interventions

- **DRUG:** deksmedetomidine
- **DRUG:** Remifentanil
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02104297
- **Lead sponsor:** Diskapi Yildirim Beyazit Education and Research Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2014-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02104297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02104297, "Effect of Deksmedetomidine and Remifentanil in Extubation Agitation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02104297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*